409 related articles for article (PubMed ID: 37492224)
1. Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications.
Ordaz-Ramos A; Tellez-Jimenez O; Vazquez-Santillan K
Front Cell Dev Biol; 2023; 11():1221175. PubMed ID: 37492224
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications.
Zeng X; Liu C; Yao J; Wan H; Wan G; Li Y; Chen N
Pharmacol Res; 2021 Jan; 163():105320. PubMed ID: 33271295
[TBL] [Abstract][Full Text] [Related]
3. Signaling pathways governing breast cancer stem cells behavior.
Song K; Farzaneh M
Stem Cell Res Ther; 2021 Apr; 12(1):245. PubMed ID: 33863385
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic Pathways of Malignancy in Breast Cancer Stem Cells.
Yousefnia S; Seyed Forootan F; Seyed Forootan S; Nasr Esfahani MH; Gure AO; Ghaedi K
Front Oncol; 2020; 10():452. PubMed ID: 32426267
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer stem cells and the challenges of eradication: a review of novel therapies.
Saeg F; Anbalagan M
Stem Cell Investig; 2018; 5():39. PubMed ID: 30498750
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer stem cells, pathways and therapeutic perspectives 2011.
Nigam A
Indian J Surg; 2013 Jun; 75(3):170-80. PubMed ID: 24426422
[TBL] [Abstract][Full Text] [Related]
7. Key Epigenetic Events Involved in the Maintenance of Breast Cancer Stem Cells.
Pourmahdi M; Saber A; Rajabi A; Abdolahi S; Ebrahimi P; Safaralizadeh R
Curr Stem Cell Res Ther; 2021; 16(7):877-887. PubMed ID: 33563177
[TBL] [Abstract][Full Text] [Related]
8. Breast Cancer Stem Cells: Signaling Pathways, Cellular Interactions, and Therapeutic Implications.
Wang L; Jin Z; Master RP; Maharjan CK; Carelock ME; Reccoppa TBA; Kim MC; Kolb R; Zhang W
Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805056
[TBL] [Abstract][Full Text] [Related]
9. Self-Renewal and Pluripotency in Osteosarcoma Stem Cells' Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers.
Martins-Neves SR; Sampaio-Ribeiro G; Gomes CMF
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176108
[TBL] [Abstract][Full Text] [Related]
10. Are breast cancer stem cells the key to resolving clinical issues in breast cancer therapy?
Shima H; Yamada A; Ishikawa T; Endo I
Gland Surg; 2017 Feb; 6(1):82-88. PubMed ID: 28210556
[TBL] [Abstract][Full Text] [Related]
11. Targeting Breast Cancer-Derived Stem Cells by Dietary Phytochemicals: A Strategy for Cancer Prevention and Treatment.
Prajapati KS; Gupta S; Kumar S
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740529
[TBL] [Abstract][Full Text] [Related]
12. Advances in Biomarkers and Endogenous Regulation of Breast Cancer Stem Cells.
Chen W; Zhang L; Liu S; Chen C
Cells; 2022 Sep; 11(19):. PubMed ID: 36230903
[TBL] [Abstract][Full Text] [Related]
13. HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness.
Pupa SM; Ligorio F; Cancila V; Franceschini A; Tripodo C; Vernieri C; Castagnoli L
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638263
[TBL] [Abstract][Full Text] [Related]
14. Novel therapeutic strategies for targeting liver cancer stem cells.
Oishi N; Wang XW
Int J Biol Sci; 2011 Apr; 7(5):517-35. PubMed ID: 21552419
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA regulation of cancer stem cells in the pathogenesis of breast cancer.
Niu T; Zhang W; Xiao W
Cancer Cell Int; 2021 Jan; 21(1):31. PubMed ID: 33413418
[TBL] [Abstract][Full Text] [Related]
16. Targeting Cancer Stem Cells in Triple-Negative Breast Cancer.
Park SY; Choi JH; Nam JS
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31324052
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Strategies Against Cancer Stem Cells in Esophageal Carcinomas.
Das PK; Islam F; Smith RA; Lam AK
Front Oncol; 2020; 10():598957. PubMed ID: 33665161
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness.
Espinosa-Sánchez A; Suárez-Martínez E; Sánchez-Díaz L; Carnero A
Front Oncol; 2020; 10():1533. PubMed ID: 32984007
[TBL] [Abstract][Full Text] [Related]
19. A novel Lnc408 maintains breast cancer stem cell stemness by recruiting SP3 to suppress CBY1 transcription and increasing nuclear β-catenin levels.
Wen S; Qin Y; Wang R; Yang L; Zeng H; Zhu P; Li Q; Qiu Y; Chen S; Liu Y; Hou Y; Tang X; Liu M; Tu G
Cell Death Dis; 2021 May; 12(5):437. PubMed ID: 33934099
[TBL] [Abstract][Full Text] [Related]
20. Natural compounds as a potential modifier of stem cells renewal: Comparative analysis.
Mishra A; Pathak Y; Mishra SK; Prakash H; Tripathi V
Eur J Pharmacol; 2023 Jan; 938():175412. PubMed ID: 36427534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
